Next Article in Journal
Effects of Systemic Vibratory Therapy Combined with a Physical Activity Program in Older Adults on Fall Risk, Balance, Physical Conditioning, and Neuromuscular Variables: Study Protocol for a Randomized Controlled Trial
Previous Article in Journal
A Generalized Responsible AI Framework for Trustworthy Clinical Prediction: Explainability, Fairness, Performance, and Uncertainty in Alzheimer’s Disease Modeling
Previous Article in Special Issue
Free Riding in Healthcare Through a Game-Theoretic Lens: A Cross-Domain Narrative Review and Conceptual Synthesis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Economic Burden of RSV-Associated Hospitalizations in Switzerland: A Nationwide Analysis (2017–2023)

by
Maria Boesing
1,2,
Daphne McCarthy-Pontier
3,
Joerg Daniel Leuppi
1,2 and
Nike Julia Kräutler
3,*
1
University Institute of Internal Medicine, Kantonsspital Baselland, 4410 Liestal, Switzerland
2
Faculty of Medicine, University of Basel, 4056 Basel, Switzerland
3
Moderna Switzerland GmbH, 4052 Basel, Switzerland
*
Author to whom correspondence should be addressed.
Healthcare 2026, 14(12), 1722; https://doi.org/10.3390/healthcare14121722 (registering DOI)
Submission received: 15 April 2026 / Revised: 5 June 2026 / Accepted: 10 June 2026 / Published: 15 June 2026
(This article belongs to the Special Issue Healthcare Economics, Management, and Innovation for Health Systems)

Abstract

Background/Objectives: Respiratory syncytial virus (RSV) is a major cause of respiratory illness across the lifespan, yet its health-economic burden in adults remains under-recognized. Building on a previously published nationwide analysis of RSV-associated hospitalizations in Switzerland (2017–2023), this study aimed to estimate age-specific direct inpatient hospitalization costs and assess their implications for healthcare systems. Methods: We conducted a nationwide health-economic analysis using Swiss Federal Statistical Office (FSO) hospitalization data (2017–2023) combined with SwissDRG-based cost statistics (2024). Age-specific costs per hospitalization were applied to RSV-associated hospitalization counts. To account for disease severity, additional estimates were derived by applying RSV-specific length-of-stay (LOS) ratios between RSV-associated and all-cause hospitalizations, reflecting the longer duration of RSV-associated admissions. Results: Total RSV-associated hospitalization costs were estimated at CHF 55.1–76.0 million annually. Children aged 0–9 years accounted for the highest number of hospitalizations and the largest share of total costs (CHF 27.8–34.3 million). Despite fewer hospitalizations, adults aged ≥ 60 years generated comparable total costs (CHF 23.6–36.7 million), driven by substantially higher costs per case. Costs increased markedly with age, reflecting longer hospital stays and higher clinical severity. Additional analyses demonstrated a substantial increase in costs in the post-pandemic period, particularly in older adults, suggesting improved detection of RSV-associated hospitalizations. Conclusions: RSV-associated hospitalizations impose a substantial economic burden on the Swiss healthcare system. The disproportionate contribution of older adults highlights the importance of targeted prevention strategies and provides a foundation for future health-economic evaluations and policy decision-making.
Keywords: respiratory syncytial virus (RSV); hospitalization; health economics; hospitalization costs; length of stay; older adults; aging population; vaccination Switzerland respiratory syncytial virus (RSV); hospitalization; health economics; hospitalization costs; length of stay; older adults; aging population; vaccination Switzerland
Graphical Abstract

Share and Cite

MDPI and ACS Style

Boesing, M.; McCarthy-Pontier, D.; Leuppi, J.D.; Kräutler, N.J. Economic Burden of RSV-Associated Hospitalizations in Switzerland: A Nationwide Analysis (2017–2023). Healthcare 2026, 14, 1722. https://doi.org/10.3390/healthcare14121722

AMA Style

Boesing M, McCarthy-Pontier D, Leuppi JD, Kräutler NJ. Economic Burden of RSV-Associated Hospitalizations in Switzerland: A Nationwide Analysis (2017–2023). Healthcare. 2026; 14(12):1722. https://doi.org/10.3390/healthcare14121722

Chicago/Turabian Style

Boesing, Maria, Daphne McCarthy-Pontier, Joerg Daniel Leuppi, and Nike Julia Kräutler. 2026. "Economic Burden of RSV-Associated Hospitalizations in Switzerland: A Nationwide Analysis (2017–2023)" Healthcare 14, no. 12: 1722. https://doi.org/10.3390/healthcare14121722

APA Style

Boesing, M., McCarthy-Pontier, D., Leuppi, J. D., & Kräutler, N. J. (2026). Economic Burden of RSV-Associated Hospitalizations in Switzerland: A Nationwide Analysis (2017–2023). Healthcare, 14(12), 1722. https://doi.org/10.3390/healthcare14121722

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop